D. Greiling et R. Thieroffekerdt, 1-ALPHA,25-DIHYDROXYVITAMIN-D-3 RAPIDLY INHIBITS FIBROBLAST-INDUCED COLLAGEN GEL CONTRACTION, Journal of investigative dermatology, 106(6), 1996, pp. 1236-1241
1 alpha a,25-Dihydroxyvitamin D-3 (1,25-D-3) inhibits the proliferatio
n of fibroblasts in vitro in monolayer culture, We investigated the ef
fect of 1,25-D-3 on normal murine and human fibroblasts cultured in co
llagen type I gels, which more closely resembles the in vivo situation
in the dermis, In this culture system 1,25-D-3 had no effect on fibro
blast proliferation; however, the fibroblast-induced collagen gel cont
raction was inhibited in a time- and concentration-dependent manner in
the nanomolar concentration range. 25-Hydroxyvitamin D-3 and 24,25-di
hydroxyvitamin D-3 were inactive, 1,25-D-3 had no effect in fibroblast
s lacking a functional vitamin D receptor, Pretreatment of fibroblasts
in monolayer culture for 5 min was sufficient to trigger the inhibiti
on of collagen gel contraction, Nifedipine increased collagen gel cont
raction and counteracted the effect of 1,25-D-3. The inhibition of col
lagen gel contraction by 1,25-D-3 is supposed to be mediated by the vi
tamin D receptor because a functional vitamin D receptor is required,
and vitamin D metabolites with low affinity to the vitamin D receptor
were inactive, Brief pretreatment of fibroblasts was sufficient to tri
gger the inhibitory effect of 1,25-D-3, suggesting a nongenomic effect
. A genomic mode of action could not be ruled out, however, because th
e inhibition was first measured after 24 h. The antagonism of the calc
ium channel antagonist nifedipine probably represents the sum of two o
pposite effects rather than supporting evidence for a nongenomic mode
of action of 1,25-D-3. In conclusion, 1,25-D-3 has a specific and rapi
dly triggered inhibitory effect on fibroblast-induced collagen gel con
traction.